Found 13 matching trials
A Study of YL201 in Patients With Advanced Solid Tumors PHASE1 This is a phase 1, multicenter, nonrandomized, open-label, first-in-human s...
Show More Learn More & Join Trial
Study of Tarlatamab in Combination With YL201 With or Without Anti-programmed Death Ligand 1 (PD-L1) in Participants With Extensive Stage (ES) Small Cell Lung Cancer (SCLC) PHASE1 The primary objective of this study is to evaluate the safety and tolerabil...
Show More Status
Active Not Recruiting
Location
City of Hope Orange County Lennar Foundation Cancer Center
Learn More & Join Trial
A Phase II Study to Evaluate the Safety, Efficacy, and Pharmacokinetics of YL201 in Patients With mCRPC PHASE2 This is a multicenter, open-label, phase II study of YL201 in China to eval...
Show More Location
Anhui Provincial Hospital
Learn More & Join Trial
A Study of YL201 and Ivonescimab (AK112) in Advanced Solid Tumors PHASE1 This study was designed to evaluate the efficacy and safety of YL201 in com...
Show More Location
Sun Yat-sen University Cancer Center
Learn More & Join Trial
A Study YL201 in Patients With Selected Advanced Solid Tumors PHASE1 This is A Multicenter, Open-Label, Phase 1/2 Study to Evaluate the Safety, ...
Show More Status
Active Not Recruiting
Location
Anhui Provincial Cancer Hospital
Learn More & Join Trial
A Study of YL201 in Combination With Toripalimab and With or Without Cisplatin in Nasopharyngeal Carcinoma. PHASE1 This is a multicenter, open-label, Phase Ib/II study conducted in China to ...
Show More Location
Chongqing University Cancer Hospital
Learn More & Join Trial
A Phase III Study of YL201 in Recurrent or Metastatic Nasopharyngeal Carcinoma PHASE3 This study was designed to compare the efficacy and safety of YL201 with In...
Show More Location
Sun Yat-sen University Cancer Center
Learn More & Join Trial
Rare Tumor Focused Platform Study of Innovative Therapies and Technologies (PLATFORM2) PHASE1 The goal of this Phase I/II observational and interventional platform study...
Show More Location
Multiple Locations
Learn More & Join Trial
A Phase III Study of YL201 in Relapsed Small Cell Lung Cancer PHASE3 This study was designed to compare the efficacy and safety of YL201 with To...
Show More Status
Active Not Recruiting
Location
Sun Yat-sen University Cancer Center
Learn More & Join Trial
A Study of YL201 in Combination With Serplulimab in Participants With Treatment-naïve Extensive-stage Small Cell Lung Cancer PHASE3 This trial is a registrational Phase III, randomized, open-label, multicent...
Show More Location
Sun Yat-sen University Cancer Center
Learn More & Join Trial